Literature DB >> 12174391

The anabolic effects of recombinant human growth hormone and glutamine on parenterally fed, short bowel rats.

Yan Gu1, Zhao-Han Wu.   

Abstract

AIM: To evaluate the metabolic effects associated with administration of rhGH and/or Gln in parenterally fed, short-bowel rats.
METHODS: Forty SD rats subjected to 75 % intestinal resection and maintained with parenteral nutrition were randomly divided into 4 groups as follows: -rhGH, -Gln; -rhGH, +Gln; +rhGH, -Gln; +rhGH, +Gln. Body weight and nitrogen balance were evaluated daily. After 6 days of PN, rats were killed, various organs were dissected and weighted, the carcasses were used for analysis of body composition. Serum GH and IGF-1 were determined by RIA method.
RESULTS: Weight loss in rats with rhGH (17.4+/-12.8 g) and rhGH+Gln (23.8+/-3.5 g) was significantly less than rats with PN alone (29.6+/-6. 9 g) and rats with Gln-supplemented PN (31.85+/-12.8 g), P<0.05. The accumulated NB in rats with rhGH (1252.9+/-294.3 mg N/d) and rhGH+Gln (1261.7+/-85.5 mg N/d) was significantly greater than those with PN alone (704.8+/-379.0 mg N/d) and with Gln-supplemented PN (856.7+/-284.4 mg N/d), P<0.05. The absolute weight of gastrocnemius muscle in rats with rhGH (2683.9+/-341.6 mg) and rhGH+Gln (2579.1+/-359.5 mg) was greater than those with PN alone (2176.3+/-167.1 mg) and with Gln-supplemented PN (2141.9+/-353.6 mg). Although the absolute weight of remnant small intestine itself was not significantly different in 4 experimental groups, the weight/length of the segments was greater in rats with rhGH and/or Gln (48.7+/-5.5, 52.7+/-4.1 and 67.4+/-5.3 respectively) than those with PN alone(47.8+/-5.0), there were synergistic effects between rhGH and Gln in improvement of the weight/length of remnant small intestine, P<0.05. Analyses of body carcass composition showed that a higher percentage of carcass weight as protein and a lower percentage of carcass weight as fat were occurred in rats with rhGH (20.8+/-4.0,6.0+/-2.6) and rhGH+Gln(21.3+/-2.4,4.4+/-1.5) than those with PN alone (16.4+/-2.4,9.2+/-3.7) and with Gln-supplemented PN (17.8+/-3.0, 6.3+/-2.0), rhGH had significant effects on alteration of body composition, P<0.05. Serum GH and IGF-1 concentration in rats with rhGH(5.221+/-0.8 and 425.1+/-19.2 ng/ml respectively)and rhGH+Gln(5.507+/-1.0 and 461.1+/-49.9 ng/ml respectively) were greater than those with PN alone(3.327+/-1.7 and 325.8+/-29.6 ng/ml respectively) and with Gln-supplemented PN(3.433+/-0.1 and 347.7+/-55.7 ng/ml respectively), P<0.01.
CONCLUSION: rhGH significantly improves the anabolism in parenterally fed. short bowel rats, anabolic effect with Gln is less dramatic, there is no synergistic effect between rhGH and Gln in improvement of whole body anabolism. IGF-1 plays an important part in growth-promoting effects of rhGH.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12174391      PMCID: PMC4656333          DOI: 10.3748/wjg.v8.i4.752

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  50 in total

1.  Effect of bowel rehabilitative therapy on structural adaptation of remnant small intestine: animal experiment.

Authors:  X Zhou; Y X Li; N Li; J S Li
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Overview of intestinal adaptation and its stimulation.

Authors:  M K Robinson; T R Ziegler; D W Wilmore
Journal:  Eur J Pediatr Surg       Date:  1999-08       Impact factor: 2.191

Review 3.  Nutritional regulation of the insulin-like growth factors.

Authors:  J P Thissen; J M Ketelslegers; L E Underwood
Journal:  Endocr Rev       Date:  1994-02       Impact factor: 19.871

4.  Regulation of insulin-like growth factor-I and growth hormone receptor gene expression by diabetes and nutritional state in rat tissues.

Authors:  K E Bornfeldt; H J Arnqvist; B Enberg; L S Mathews; G Norstedt
Journal:  J Endocrinol       Date:  1989-09       Impact factor: 4.286

Review 5.  Short bowel syndrome in infants and children.

Authors:  M Z Schwartz; K Maeda
Journal:  Pediatr Clin North Am       Date:  1985-10       Impact factor: 3.278

6.  Anabolic therapy with growth hormone accelerates protein gain in surgical patients requiring nutritional rehabilitation.

Authors:  T A Byrne; T B Morrissey; C Gatzen; K Benfell; T V Nattakom; M R Scheltinga; M S LeBoff; T R Ziegler; D W Wilmore
Journal:  Ann Surg       Date:  1993-10       Impact factor: 12.969

Review 7.  Glutamine supplementation in catabolic patients.

Authors:  G S Sacks
Journal:  Ann Pharmacother       Date:  1999-03       Impact factor: 3.154

8.  Glutamine enhancement of structure and function in transplanted small intestine in the rat.

Authors:  W L Frankel; W Zhang; J Afonso; D M Klurfeld; S H Don; E Laitin; D Deaton; E E Furth; G G Pietra; A Naji
Journal:  JPEN J Parenter Enteral Nutr       Date:  1993 Jan-Feb       Impact factor: 4.016

9.  Simultaneous treatment with IGF-I and GH additively increases anabolism in parenterally fed rats.

Authors:  H C Lo; P S Hinton; C A Peterson; D M Ney
Journal:  Am J Physiol       Date:  1995-08

10.  Expression and regulation of insulin-like growth factor-I (IGF-I) and IGF-binding protein messenger ribonucleic acid levels in tissues of hypophysectomized rats infused with IGF-I and growth hormone.

Authors:  M A Gosteli-Peter; K H Winterhalter; C Schmid; E R Froesch; J Zapf
Journal:  Endocrinology       Date:  1994-12       Impact factor: 4.736

View more
  19 in total

Review 1.  Gut in diseases: physiological elements and their clinical significance.

Authors:  Lian-An Ding; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

2.  Changes of biological functions of dipeptide transporter (PepT1) and hormonal regulation in severe scald rats.

Authors:  Bing-Wei Sun; Xiao-Chen Zhao; Guang-Ji Wang; Ning Li; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

Review 3.  Somatropin (Zorbtive): in short bowel syndrome.

Authors:  Gillian M Keating; Keri Wellington
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Effects of recombinant human growth hormone on growth of human gastric carcinoma xenograft model in nude mice.

Authors:  Dao-Ming Liang; Jia-Yong Chen; Yi Zhang; Ping Gan; Jie Lin; An-Bao Chen
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

5.  Hormonal regulation of dipeptide transporter (PepT1) in Caco-2 cells with normal and anoxia/reoxygenation management.

Authors:  Bing-Wei Sun; Xiao-Chen Zhao; Guang-Ji Wang; Ning Li; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

Review 6.  Intestinal mucosal adaptation.

Authors:  Laurie Drozdowski; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

7.  Effects of recombinant human growth hormone on rat septic shock with intraabdominal infection by E. coli.

Authors:  Ying Huang; Shu-Ren Wang; Cheng Yi; Ming-Ying Ying; Ying Lin; Mao-Hui Zhi
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

Review 8.  Morphological, kinetic, membrane biochemical and genetic aspects of intestinal enteroplasticity.

Authors:  Laurie A Drozdowski; M Tom Clandinin; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

9.  Effects of recombinant human growth hormone on remnant liver after hepatectomy in hepatocellular carcinoma with cirrhosis.

Authors:  Shi-Min Luo; Li-Jian Liang; Jia-Ming Lai
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

Review 10.  New and emerging therapies for short bowel syndrome in children.

Authors:  Jon A Vanderhoof; Rosemary J Young; Jon S Thompson
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.